BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 38736105)

  • 1. Sarcomatoid and Rhabdoid Renal Cell Carcinoma: Clinical, Pathologic, and Molecular Genetic Features.
    Adeniran AJ; Shuch B; Humphrey PA
    Am J Surg Pathol; 2024 May; ():. PubMed ID: 38736105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult renal cell carcinoma with rhabdoid differentiation: incidence and clinicopathologic features in Chinese patients.
    Yang X; Xi C; Jin J; Zhou L; Su J; Liu L; Liu Y
    Ann Diagn Pathol; 2015 Apr; 19(2):57-63. PubMed ID: 25708024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma with rhabdoid features.
    Gökden N; Nappi O; Swanson PE; Pfeifer JD; Vollmer RT; Wick MR; Humphrey PA
    Am J Surg Pathol; 2000 Oct; 24(10):1329-38. PubMed ID: 11023094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult renal cell carcinoma with rhabdoid morphology represents a neoplastic dedifferentiation analogous to sarcomatoid carcinoma.
    Chapman-Fredricks JR; Herrera L; Bracho J; Gomez-Fernandez C; Leveillee R; Rey L; Jorda M
    Ann Diagn Pathol; 2011 Oct; 15(5):333-7. PubMed ID: 21665507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal cell carcinoma with sarcomatoid and rhabdoid features: a clinico-pathological series of 74 cases].
    Queipo FJ; Panizo A; Sola JJ; Beorlegui C; Velis JM; Dolezal P; Pardo-Mindán J
    An Sist Sanit Navar; 2018 Aug; 41(2):191-199. PubMed ID: 30063035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed death ligand 1/indoleamine 2,3-dioxygenase 1 expression and tumor-infiltrating lymphocyte status in renal cell carcinoma with sarcomatoid changes and rhabdoid features.
    Kiyozawa D; Takamatsu D; Kohashi K; Kinoshita F; Ishihara S; Toda Y; Eto M; Oda Y
    Hum Pathol; 2020 Jul; 101():31-39. PubMed ID: 32360490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically.
    Yang B; Xia H; Xu C; Lu M; Zhang S; Wang G; Ma L
    BMC Urol; 2020 Feb; 20(1):14. PubMed ID: 32070319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
    Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
    Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of sarcomatoid and rhabdoid dedifferentiation in renal cell carcinoma.
    Hahn AW; Lebenthal J; Genovese G; Sircar K; Tannir NM; Msaouel P
    Cancer Treat Res Commun; 2022; 33():100640. PubMed ID: 36174377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of renal cell carcinoma with rhabdoid features with focus on clinical and pathobiological aspects.
    Kuroda N; Karashima T; Inoue K; Kasajima A; Ohe C; Kawakami F; Mikami S; Matsuura K; Moriyama M; Nagashima Y; Petersson F; Lopez JI; Cohen RJ; Michal M; Hes O
    Pol J Pathol; 2015 Mar; 66(1):3-8. PubMed ID: 26017874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive peritoneal carcinomatosis secondary to renal cell carcinoma with sarcomatoid and rhabdoid differentiation.
    Esnakula AK; Naab TJ; Green W; Shokrani B
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23608849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Rhabdoid Differentiation on Prognosis for Patients with Grade 4 Renal Cell Carcinoma.
    Zhang BY; Cheville JC; Thompson RH; Lohse CM; Boorjian SA; Leibovich BC; Costello BA
    Eur Urol; 2015 Jul; 68(1):5-7. PubMed ID: 25638439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
    Trpkov K; Hes O; Williamson SR; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Gill AJ
    Mod Pathol; 2021 Jul; 34(7):1392-1424. PubMed ID: 33664427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological features and prognosis of renal cell carcinoma with sarcomatoid differentiation].
    Jiang Y; Su G; Yu W; Li J; Lu Q; Li Y; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):823-6. PubMed ID: 26887511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired cystic disease-associated renal cell carcinoma with sarcomatoid change and rhabdoid features.
    Kuroda N; Tamura M; Hamaguchi N; Mikami S; Pan CC; Brunelli M; Martignoni G; Hes O; Michal M; Lee GH
    Ann Diagn Pathol; 2011 Dec; 15(6):462-6. PubMed ID: 21036640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SWI/SNF chromatin-remodeling complex status in renal cell carcinomas with sarcomatoid or rhabdoid features.
    Kinoshita F; Kohashi K; Sugimoto M; Takamatsu D; Kiyozawa D; Eto M; Oda Y
    Virchows Arch; 2020 Nov; 477(5):651-660. PubMed ID: 32447490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma.
    McKay RR; Bossé D; Xie W; Wankowicz SAM; Flaifel A; Brandao R; Lalani AA; Martini DJ; Wei XX; Braun DA; Van Allen E; Castellano D; De Velasco G; Wells JC; Heng DY; Fay AP; Schutz FA; Hsu J; Pal SK; Lee JL; Hsieh JJ; Harshman LC; Signoretti S; Motzer RJ; Feldman D; Choueiri TK
    Cancer Immunol Res; 2018 Jul; 6(7):758-765. PubMed ID: 29748390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cell carcinoma with rhabdoid-like features lack intracytoplasmic inclusion bodies and show aggressive behavior.
    Sugimoto M; Kohashi K; Kuroiwa K; Abe T; Yamada Y; Shiota M; Imada K; Naito S; Oda Y
    Virchows Arch; 2016 Mar; 468(3):357-67. PubMed ID: 26649732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation.
    Joseph RW; Millis SZ; Carballido EM; Bryant D; Gatalica Z; Reddy S; Bryce AH; Vogelzang NJ; Stanton ML; Castle EP; Ho TH
    Cancer Immunol Res; 2015 Dec; 3(12):1303-7. PubMed ID: 26307625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhabdoid and Undifferentiated Phenotype in Renal Cell Carcinoma: Analysis of 32 Cases Indicating a Distinctive Common Pathway of Dedifferentiation Frequently Associated With SWI/SNF Complex Deficiency.
    Agaimy A; Cheng L; Egevad L; Feyerabend B; Hes O; Keck B; Pizzolitto S; Sioletic S; Wullich B; Hartmann A
    Am J Surg Pathol; 2017 Feb; 41(2):253-262. PubMed ID: 27984237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.